Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer.

Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, Moore AL, Tsukrov DI, Kempner ME, Dahl DM, Wu CL, Iafrate AJ, Smith MR, Tompkins RG, Sequist LV, Toner M, Haber DA, Maheswaran S.

Sci Transl Med. 2010 Mar 31;2(25):25ra23. doi: 10.1126/scitranslmed.3000403.

2.

Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device.

Kirby BJ, Jodari M, Loftus MS, Gakhar G, Pratt ED, Chanel-Vos C, Gleghorn JP, Santana SM, Liu H, Smith JP, Navarro VN, Tagawa ST, Bander NH, Nanus DM, Giannakakou P.

PLoS One. 2012;7(4):e35976. doi: 10.1371/journal.pone.0035976. Epub 2012 Apr 27. Erratum in: PLoS One. 2012;7(7): doi/10.1371/annotation/9d3d22ed-dc5a-4484-9254-1584864f4aac.

3.

High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.

Fizazi K, Morat L, Chauveinc L, Prapotnich D, De Crevoisier R, Escudier B, Cathelineau X, Rozet F, Vallancien G, Sabatier L, Soria JC.

Ann Oncol. 2007 Mar;18(3):518-21.

PMID:
17322541
4.

The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.

Theil G, Fischer K, Weber E, Medek R, Hoda R, Lücke K, Fornara P.

PLoS One. 2016 Aug 1;11(8):e0158354. doi: 10.1371/journal.pone.0158354. eCollection 2016.

5.

Tumorigenic potential of circulating prostate tumor cells.

Carvalho FL, Simons BW, Antonarakis ES, Rasheed Z, Douglas N, Villegas D, Matsui W, Berman DM.

Oncotarget. 2013 Mar;4(3):413-21.

6.

Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.

Kolostova K, Broul M, Schraml J, Cegan M, Matkowski R, Fiutowski M, Bobek V.

Anticancer Res. 2014 Jul;34(7):3641-6.

PMID:
24982381
7.

Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.

Chen CL, Mahalingam D, Osmulski P, Jadhav RR, Wang CM, Leach RJ, Chang TC, Weitman SD, Kumar AP, Sun L, Gaczynska ME, Thompson IM, Huang TH.

Prostate. 2013 Jun;73(8):813-26. doi: 10.1002/pros.22625. Epub 2012 Dec 31.

8.

Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.

Helo P, Cronin AM, Danila DC, Wenske S, Gonzalez-Espinoza R, Anand A, Koscuiszka M, Väänänen RM, Pettersson K, Chun FK, Steuber T, Huland H, Guillonneau BD, Eastham JA, Scardino PT, Fleisher M, Scher HI, Lilja H.

Clin Chem. 2009 Apr;55(4):765-73. doi: 10.1373/clinchem.2008.117952. Epub 2009 Feb 20.

9.

Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer.

O'Hara SM, Moreno JG, Zweitzig DR, Gross S, Gomella LG, Terstappen LW.

Clin Chem. 2004 May;50(5):826-35. Epub 2004 Feb 26.

10.

Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.

Shao C, Liao CP, Hu P, Chu CY, Zhang L, Bui MH, Ng CS, Josephson DY, Knudsen B, Tighiouart M, Kim HL, Zhau HE, Chung LW, Wang R, Posadas EM.

PLoS One. 2014 Feb 14;9(2):e88967. doi: 10.1371/journal.pone.0088967. eCollection 2014.

11.

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip.

Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK, Floyd FP Jr, Gilman AJ, Lord JB, Winokur D, Springer S, Irimia D, Nagrath S, Sequist LV, Lee RJ, Isselbacher KJ, Maheswaran S, Haber DA, Toner M.

Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18392-7. doi: 10.1073/pnas.1012539107. Epub 2010 Oct 7.

12.

Sample-to-Answer Isolation and mRNA Profiling of Circulating Tumor Cells.

Mohamadi RM, Ivanov I, Stojcic J, Nam RK, Sargent EH, Kelley SO.

Anal Chem. 2015 Jun 16;87(12):6258-64. doi: 10.1021/acs.analchem.5b01019. Epub 2015 Jun 2.

PMID:
26009151
13.

Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer.

Aragon-Ching JB, Siegel RS, Frazier H 2nd, Andrawis R, Hendricks F, Phillips M, Jarrett T, Guebre-Xabiher H, Patierno S, Simmens SJ.

Clin Genitourin Cancer. 2015 Oct;13(5):e341-5. doi: 10.1016/j.clgc.2015.04.003. Epub 2015 Apr 18.

PMID:
25956468
14.

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer.

Magbanua MJ, Sosa EV, Scott JH, Simko J, Collins C, Pinkel D, Ryan CJ, Park JW.

BMC Cancer. 2012 Feb 28;12:78. doi: 10.1186/1471-2407-12-78.

15.

mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.

Cann GM, Gulzar ZG, Cooper S, Li R, Luo S, Tat M, Stuart S, Schroth G, Srinivas S, Ronaghi M, Brooks JD, Talasaz AH.

PLoS One. 2012;7(11):e49144. doi: 10.1371/journal.pone.0049144. Epub 2012 Nov 7.

16.

Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.

Ali A, Furusato B, Ts'o PO, Lum ZP, Elsamanoudi S, Mohamed A, Srivastava S, Moul JW, Brassell SA, Sesterhenn IA, McLeod DG.

Pathol Int. 2010 Oct;60(10):667-72. doi: 10.1111/j.1440-1827.2010.02584.x.

PMID:
20846264
17.

Ad5/35E1aPSESE4: A novel approach to marking circulating prostate tumor cells with a replication competent adenovirus controlled by PSA/PSMA transcription regulatory elements.

Hwang JE, Joung JY, Shin SP, Choi MK, Kim JE, Kim YH, Park WS, Lee SJ, Lee KH.

Cancer Lett. 2016 Mar 1;372(1):57-64. doi: 10.1016/j.canlet.2015.12.018. Epub 2015 Dec 23.

18.

Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status.

Moreno JG, O'Hara SM, Gross S, Doyle G, Fritsche H, Gomella LG, Terstappen LW.

Urology. 2001 Sep;58(3):386-92.

PMID:
11549486
19.

The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer.

Saad F, Pantel K.

Future Oncol. 2012 Mar;8(3):321-31. doi: 10.2217/fon.12.3. Review.

PMID:
22409467
20.

Circulating tumor cell detection in high-risk non-metastatic prostate cancer.

Loh J, Jovanovic L, Lehman M, Capp A, Pryor D, Harris M, Nelson C, Martin J.

J Cancer Res Clin Oncol. 2014 Dec;140(12):2157-62. doi: 10.1007/s00432-014-1775-3. Epub 2014 Jul 16.

PMID:
25028119

Supplemental Content

Support Center